Budesonide/formoterol (DrugBank: Formoterol, Budesonide)
1 diseaseID | Disease name (Link within this page) | Number of trials |
---|---|---|
228 | Bronchiolitis obliterans | 2 |
No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | NCT01560689 (ClinicalTrials.gov) | June 2008 | 20/3/2012 | Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans Following Stem Cell Transplantation | Open-labeled Trial to Evaluate the Therapeutic Effects of Inhaled BUDESONIDE/FORMOTEROL in Bronchiolitis Obliterans After Allogeneic Stem Cell Transplantation | Bronchiolitis Obliterans;Allogeneic Stem Cell Transplantation | Drug: Budesonide/formoterol;Drug: Placebo | Assistance Publique - Hôpitaux de Paris | NULL | Completed | 16 Years | N/A | Both | 32 | Phase 2 | France |
2 | NCT00624754 (ClinicalTrials.gov) | March 2008 | 15/2/2008 | Prospective Evaluation of the Efficacy of Budesonide/Formoterol in Bronchiolitis Obliterans in AHSCT | recipientsProspective Evaluation of the Efficacy of Budesonide/Formoterol (Symbicort®) in Bronchiolitis Obliterans in Allogeneic Haematopoietic Stem Cell Transplantation (AHSCT) Recipients | Obstructive Airway Disease | Drug: Formoterol/Budesonide;Drug: lactose | Assistance Publique - Hôpitaux de Paris | AstraZeneca | Completed | 16 Years | N/A | Both | 32 | Phase 2 | France |